(Q28374317)
Statements
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial (English)
0 references
21 March 2000
0 references
132
0 references
6
0 references
425-34
0 references